global-immunoassay-technologies-market-industry
Published

MAR 2018

Global Immunoassays Market - Segmented by Technology, Therapeutics Area, and End Users - Growth, Trends, and Forecast (2018 - 2023)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global Immunoassay market was estimated at 17.16 billion in 2017. The global immunoassays market is expected to register a CAGR of 9.7% during the forecast period, 2018 to 2023. North America dominates the market due to the technological advancement in immunoassay products and rising incidence of chronic diseases like thyroid and cardiovascular diseases.

High Sensitivity and Specificity

Compared to conventional tests, immunoassays have been proven to provide highly accurate results even with very small samples. Immunoassays are considered to have a detection limit of 1pg/ml. This can be attributed to the fact that immunoassays are based entirely on immunologic reactions. Immunologic reactions are highly specific as they can take place only in the presence of proper immunologic agents.  Immunoassays have a range of applications in pharmaceutical analysis such as diagnosis of disease, therapeutic drug monitoring, clinical pharmacokinetics and bioequivalence in drug discovery and pharmaceutical industries.

Additionally, cost-effective and rapid analysis by immunoassays and growth in the biotechnology and pharmaceutical sectors are also driving the growth of the global immunoassays market.

Limitations Associated with Immunoassay

Immunoassays have shown high sensitivity and specificity. While they have advantages, there have been many limitations associated with the procedure. The limit of detection (LOD) for most of the immunoassays is limited, primarily by the signal-to-noise ratio provided by the instrument that is used to detect antibody-antigen binding or by non-specific binding (NSB). Immunoassays are very complex to develop and manufacture and employ complex biomolecules, such as antibodies, antigens, and enzymes for the detection of the target molecules. Additionally, complex assay procedures are also acting as a restraint for the global immunoassays market.

North America to Dominate the Market

The market has been segmented by technology into enzyme immunoassay, fluorescence immunoassay, chemiluminescence immunoassay, radioimmunoassay, nephelometric immunoassay, and others. Based on therapeutic areas, it has been segmented into cardiology, thyroid, autoimmune disease, oncology, infectious disease, hematology, allergy, and others. By end user, the market is segmented into hospital, centralized laboratory, academic institution, pharma & biotech firm, contract research organization, and others. The market is segmented on the basis of geography into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The regions have been further divided into major constituent countries.

North America dominates the global immunoassays market, which is mainly driven by increasing incidence of chronic disease and use of immunoassays in oncology.

Key Developments in the Market

  • September 2017: Meridian Life science Inc. launched TRUBlock Ultra, which is an active immunoassay interference blocker created by HAMA, rheumatoid factor (RH), and heterophillic antibodies (HA). 
  • June 2017: Qiagen developed QFT-Plus, which detects latent tuberculosis infection got FDA approval.

Major Players: Abbott Laboratories Inc., Becton Dickinson and Company, Danaher Corporation (Beckman Coulter), Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Luminex Corporation, Meridian Life Science Inc., and Qiagen, among others

Reasons to Purchase this Report

  • Current and future immunoassays market outlook in the developed and emerging markets
  • Analyze various perspectives of the market with the help of Porter’s five forces analysis
  • The treatment type that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

  • This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

 

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?